West Pharmaceutical Services | WST - Interest Expense On Debt


West Pharmaceutical Services reported $1.9M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Align Technology USD 16.04M 14.04M Dec/2025
Avanos Medical USD 1.9M 100K Dec/2025
Baxter International USD 58M 14M Sep/2025
Becton, Dickinson and Co. USD 149M 4M Mar/2026
Cerus USD 2.33M 96K Jun/2024
Charles River Laboratories USD 26.74M 2.97M Mar/2026
Cooper Companies USD 20.9M 1.5M Mar/2026
Dentsply International USD 24M 2M Mar/2026
Haemonetics USD 7.4M 190K Dec/2025
ICU Medical USD 20.64M 21.39M Dec/2025
Insulet USD 14.7M 5.5M Mar/2026
Integra LifeSciences USD 22.46M 1.21M Mar/2026
IQVIA Holdings USD 192M 1000K Mar/2026
J&J USD 43M 25M Mar/2026
Medtronic USD 176M 5M Mar/2026
Merit Medical Systems USD 6.53M 162K Mar/2026
Neogen USD 13.9M 356K Dec/2025
OraSure Technologies 1.67M 1.13M Dec/2025
Quidel USD 5.63B 5.58B Mar/2026
Repligen USD 5.58M 83K Mar/2026
Rockwell Medical USD 232K 199K Jun/2024
Solventum Corp USD 14.1B 14.05B Mar/2026
STAAR Surgical USD 800K 799K Sep/2025
Terumo JPY 1.53B 1.06B Mar/2026
West Pharmaceutical Services USD 1.9M 1.7M Mar/2026